Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.
Jakob C, Sterz J, Liebisch P, Mieth M, Rademacher J, Goerke A, Heider U, Fleissner C, Kaiser M, von Metzler I, Müller C, Sezer O. Jakob C, et al. Among authors: fleissner c. Leukemia. 2008 Sep;22(9):1767-72. doi: 10.1038/leu.2008.159. Epub 2008 Jun 26. Leukemia. 2008. PMID: 18580957
Bortezomib inhibits human osteoclastogenesis.
von Metzler I, Krebbel H, Hecht M, Manz RA, Fleissner C, Mieth M, Kaiser M, Jakob C, Sterz J, Kleeberg L, Heider U, Sezer O. von Metzler I, et al. Among authors: fleissner c. Leukemia. 2007 Sep;21(9):2025-34. doi: 10.1038/sj.leu.2404806. Epub 2007 Jun 21. Leukemia. 2007. PMID: 17581612
Serum levels of carboxy-terminal telopeptide of type-I collagen are elevated in patients with multiple myeloma showing skeletal manifestations in magnetic resonance imaging but lacking lytic bone lesions in conventional radiography.
Jakob C, Zavrski I, Heider U, Bollow M, Schulz CO, Fleissner C, Eucker J, Michael R, Hamm B, Possinger K, Sezer O. Jakob C, et al. Among authors: fleissner c. Clin Cancer Res. 2003 Aug 1;9(8):3047-51. Clin Cancer Res. 2003. PMID: 12912955
Bone markers in multiple myeloma.
Heider U, Fleissner C, Zavrski I, Kaiser M, Hecht M, Jakob C, Sezer O. Heider U, et al. Among authors: fleissner c. Eur J Cancer. 2006 Jul;42(11):1544-53. doi: 10.1016/j.ejca.2005.11.034. Epub 2006 Jun 9. Eur J Cancer. 2006. PMID: 16765040 Review.
Angiogenesis in multiple myeloma.
Jakob C, Sterz J, Zavrski I, Heider U, Kleeberg L, Fleissner C, Kaiser M, Sezer O. Jakob C, et al. Among authors: fleissner c. Eur J Cancer. 2006 Jul;42(11):1581-90. doi: 10.1016/j.ejca.2006.02.017. Epub 2006 Jun 23. Eur J Cancer. 2006. PMID: 16797965 Review.
28 results